Lataa...
Novel targeted therapeutics for metastatic castration-resistant prostate cancer
Virtually all patients that succumb to prostate cancer die of metastatic castration-resistant disease. Although docetaxel is the standard of care for these patients and is associated with a modest prolongation of survival, there is an urgent need for novel treatment strategies for metastatic prostat...
Tallennettuna:
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2009
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4029098/ https://ncbi.nlm.nih.gov/pubmed/19717225 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.canlet.2009.08.012 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|